Hony Capital under Legend Holdings invested RMB180M into Guangzhou Consun Pharmaceutical Co., Ltd. (Consun), on March 31.

Consun was originally No. 1 Military Medical College South Scientific Research Medicine Factory. In 1997, the factory cooperated with Hong Kong Jinana Bosi Investment Co., Ltd and Guangzhou Qian'an Investment Co., Ltd to establish the joint venture Consun.

In this investment deal, Hony Capital became Consun's shareholder through purchasing partial stake of Huibo Yang, a large shareholder of Consun, and capital increase and share expansion mode. Hony Capital President John H. Zhao said they choose Consun because of its team with military background, as well as its technical R&D capability. Conson's lead product "uremic clearance" had entered the Chinese medicine protection list issued by China FDA.

Hony Capital manages three funds with the amount reaching US$700M. It invested eighteen projects. It focuses on construction materials and medicine sectors, and is also involved in auto collision parts and consumption sectors.